HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$4.64
Day range
$4.62 - $4.93
Year range
$3.26 - $13.51
Market cap
317.44M USD
Avg Volume
861.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.06M | 42.96% |
Net income | -21.02M | -32.85% |
Net profit margin | — | — |
Earnings per share | -0.29 | 0.00% |
EBITDA | -23.99M | -43.33% |
Effective tax rate | -0.23% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 263.44M | -6.95% |
Total assets | 268.52M | -6.45% |
Total liabilities | 13.15M | 30.42% |
Total equity | 255.37M | — |
Shares outstanding | 64.65M | — |
Price to book | 1.17 | — |
Return on assets | -22.27% | — |
Return on capital | -23.35% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -21.02M | -32.85% |
Cash from operations | -19.32M | -72.30% |
Cash from investing | 47.23M | 424.71% |
Cash from financing | 13.86M | -86.92% |
Net change in cash | 42.03M | -47.63% |
Free cash flow | -11.75M | -115.26% |
About
Founded
2016
Headquarters
Website
Employees
66